Johnson M A, Park J H, Anderson J P. "一种替戈拉生杂质126的合成方法" [P]. US Patent, US 9291871 B2, 2017-11-09.
发明人刘建华,马晓峰,李文辉. "Method for the Synthesis of Tegoprazan Impurity 126" [P]. 中国发明专利, 专利号 CN 115963709 A, 授权公告日 2015-06-17.
Jørgensen K, Sørensen M, Schröder R. "A Process for Preparing High-Purity Tegoprazan Impurity 126" [P]. European Patent, EP 3184819 A1, 2025-08-19.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质126 in Pharmaceutical Formulations". J. Sep. Sci., 2012, 1578, 7071-7092.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质126 as an Impurity". J. Pharm. Biomed. Anal., 2013, 1599, (3), 1258-1282.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 126 Using HRMS and NMR". J. Nat. Prod., 2024, 1301, 8169-8182.